United Therapeutics reaches deal for Remodulin system

United Therapeutics Corp., a Silver Spring-based biotechnology company, announced it has signed an agreement with DEKA Research & Development Corp. for the development of a subcutaneous delivery of United Therapeutics’ Remodulin injection via a pre-filled, semi-disposable pump system. Remodulin is a treatment for pulmonary arterial hypertension symptoms associated with exercise. The delivery system could be ...

Leave a Reply

Your email address will not be published. Required fields are marked *